Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
Am J Hematol
; 89(2): 145-50, 2014 Feb.
Article
de En
| MEDLINE
| ID: mdl-24123068
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Leucémie à plasmocytes
/
Protocoles de polychimiothérapie antinéoplasique
Type d'étude:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Am J Hematol
Année:
2014
Type de document:
Article
Pays d'affiliation:
Grèce
Pays de publication:
États-Unis d'Amérique